West Branch Capital LLC Acquires 585 Shares of Danaher Co. (NYSE:DHR)

West Branch Capital LLC raised its position in shares of Danaher Co. (NYSE:DHR) by 106.8% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,133 shares of the conglomerate’s stock after purchasing an additional 585 shares during the period. West Branch Capital LLC’s holdings in Danaher were worth $315,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also bought and sold shares of the company. Cyndeo Wealth Partners LLC lifted its position in Danaher by 9.7% during the 3rd quarter. Cyndeo Wealth Partners LLC now owns 8,425 shares of the conglomerate’s stock worth $2,342,000 after acquiring an additional 748 shares during the period. CNB Bank lifted its holdings in shares of Danaher by 3.8% in the 3rd quarter. CNB Bank now owns 3,647 shares of the conglomerate’s stock valued at $1,014,000 after buying an additional 135 shares during the period. Revolve Wealth Partners LLC acquired a new position in Danaher in the 3rd quarter worth about $541,000. Waypoint Capital Advisors LLC raised its holdings in Danaher by 0.9% in the 3rd quarter. Waypoint Capital Advisors LLC now owns 4,520 shares of the conglomerate’s stock worth $1,257,000 after purchasing an additional 42 shares during the period. Finally, AA Financial Advisors LLC raised its holdings in Danaher by 7.3% in the 3rd quarter. AA Financial Advisors LLC now owns 2,419 shares of the conglomerate’s stock worth $673,000 after purchasing an additional 164 shares during the period. 79.05% of the stock is owned by institutional investors.

Insider Activity

In other news, SVP Georgeann Couchara sold 952 shares of the business’s stock in a transaction on Monday, August 26th. The shares were sold at an average price of $268.37, for a total transaction of $255,488.24. Following the completion of the sale, the senior vice president now directly owns 4,212 shares of the company’s stock, valued at $1,130,374.44. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In related news, SVP Georgeann Couchara sold 952 shares of Danaher stock in a transaction on Monday, August 26th. The shares were sold at an average price of $268.37, for a total transaction of $255,488.24. Following the transaction, the senior vice president now owns 4,212 shares in the company, valued at approximately $1,130,374.44. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, SVP Brian W. Ellis sold 9,600 shares of Danaher stock in a transaction on Thursday, July 25th. The shares were sold at an average price of $275.16, for a total transaction of $2,641,536.00. Following the transaction, the senior vice president now owns 20,230 shares in the company, valued at $5,566,486.80. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 39,659 shares of company stock valued at $11,042,433 in the last ninety days. Company insiders own 11.10% of the company’s stock.

Danaher Price Performance

Shares of Danaher stock traded up $2.40 during trading on Friday, hitting $274.38. 1,949,849 shares of the company were exchanged, compared to its average volume of 2,717,951. The company has a quick ratio of 1.04, a current ratio of 1.43 and a debt-to-equity ratio of 0.33. Danaher Co. has a fifty-two week low of $182.09 and a fifty-two week high of $281.70. The stock has a market capitalization of $203.23 billion, a price-to-earnings ratio of 46.51, a P/E/G ratio of 4.49 and a beta of 0.83. The firm has a 50 day moving average price of $270.72 and a 200 day moving average price of $260.02.

Danaher (NYSE:DHR) last released its earnings results on Tuesday, July 23rd. The conglomerate reported $1.72 EPS for the quarter, topping the consensus estimate of $1.57 by $0.15. The firm had revenue of $5.74 billion during the quarter, compared to analysts’ expectations of $5.59 billion. Danaher had a net margin of 16.94% and a return on equity of 11.06%. Danaher’s revenue for the quarter was down 2.9% on a year-over-year basis. During the same period in the previous year, the company earned $2.05 EPS. On average, equities analysts expect that Danaher Co. will post 7.59 earnings per share for the current fiscal year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 25th. Stockholders of record on Friday, September 27th will be paid a dividend of $0.27 per share. The ex-dividend date of this dividend is Friday, September 27th. This represents a $1.08 annualized dividend and a dividend yield of 0.39%. Danaher’s dividend payout ratio is presently 18.31%.

Analysts Set New Price Targets

DHR has been the subject of a number of analyst reports. Barclays upped their price target on Danaher from $270.00 to $285.00 and gave the stock an “equal weight” rating in a report on Wednesday, July 24th. Stifel Nicolaus upped their price target on Danaher from $235.00 to $250.00 and gave the company a “hold” rating in a research report on Wednesday, July 24th. Leerink Partners upped their price target on Danaher from $275.00 to $280.00 and gave the company an “outperform” rating in a research report on Wednesday, July 24th. Bank of America upped their price target on Danaher from $270.00 to $275.00 and gave the company a “neutral” rating in a research report on Wednesday, July 24th. Finally, Robert W. Baird increased their price objective on Danaher from $271.00 to $278.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 24th. Seven research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $282.12.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.